The FDA has approved eltrombopag (Promacta), by GlaxoSmithkline for use in patients withHepatitis C and thrombocytopenia. The drugwill be usedto increase platelet counts so patients can receive interferon-basedtreatment. What are the current treatment options for hepatitis C?
For more Information, please see the article in REUTERS.
“Image courtesy of [rajcreationzs]/ FreeDigitalPhotos.net”